FOX CHRISTINE ANN (Chief Financial Officer) sold 24.1% of their position (28.29K shares) of MEREO BIOPHARMA GROUP PLC on the open market
Open‑market sale worth $121.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/16/2024ACC: 0000950170-24-106970
Officer· Chief Financial Officer
Since Feb 2026
-28.29K
Net shares
Net seller
$121.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
28.29K disposed
Non-Derivative Transactions2
American Depositary Shares representing Ordinary Shares
Direct
Shares
−9.13K
Price / share
$4.47
Trade value
$40.83K
% of position
7.8%
9/12/2024
117.57K→108.44K
American Depositary Shares representing Ordinary Shares
Direct
Shares
−19.16K
Price / share
$4.22
Trade value
$80.87K
% of position
17.7%
9/13/2024
108.44K→89.28K
Total
Net shares
−28.29K
Net value
-$121.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 9/12/2024 | S · Sale | −9.13K | $4.47 | $40.83K | 7.8% | 117.57K | 108.44K |
| American Depositary Shares representing Ordinary Shares Direct | 9/13/2024 | S · Sale | −19.16K | $4.22 | $80.87K | 17.7% | 108.44K | 89.28K |
| Total | −28.29K | -$121.69K | ||||||
Derivative Transactions0
No derivative transactions reported